Advertisement

Anticoagulant management during percutaneous coronary intervention for a patient with antithrombin deficiency

Published:October 27, 2022DOI:https://doi.org/10.1016/j.jccase.2022.10.006

      Abstract

      Previous reports on cardiac intervention in cases with antithrombin deficiency are extremely limited. We report a case of acute coronary syndrome with antithrombin deficiency in a 62-year-old man with multiple histories of thrombosis. He had worsening chest pain, and laboratory data showed an elevated level of troponin T, suggesting acute myocardial infarction. Currently, there is no fixed anticoagulation strategy for coronary intervention in patients with antithrombin deficiency. In this case, we performed coronary intervention with heparin in addition to antithrombin concentrate. The intervention was successfully performed without thrombosis or bleeding complications.

      Learning objective

      Antithrombin deficiency is a rare disorder and data about coronary intervention for cases with antithrombin deficiency are limited. We successfully performed intervention with our anticoagulant management and it would be beneficial for future reference.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiology Cases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Patnaik M.M.
        • Moll S.
        Inherited antithrombin deficiency: a review.
        Haemophilia. 2008; 14: 1229-1239https://doi.org/10.1111/j.1365-2516.2008.01830.x
        • Nishimura Y.
        • Takagi Y.
        Strategy for cardiovascular surgery in patients with antithrombin III deficiency.
        Ann Thorac Cardiovasc Surg. 2018; 24: 187-192https://doi.org/10.5761/atcs.oa.18-00030
        • Egeberg O.
        Inherited antithrombin deficiency causing thrombophilia.
        Thromb Diath Haemorrh. 1965; 13: 516-530https://doi.org/10.1055/s-0038-1656297
        • Wells P.S.
        • Blajchman M.A.
        • Henderson P.
        • Wells M.J.
        • Demers C.
        • Bourque R.
        • McAvoy A.
        Prevalence of antithrombin deficiency in healthy blood donors: a cross-sectional study.
        Am J Hematol. 1994; 45: 321-324https://doi.org/10.1002/ajh.2830450409
        • Fennich N.
        • Salwa A.
        • Nadia B.
        • Latifa O.
        • Jamila Z.
        • Mohamed C.
        Acute coronary syndrome in a young woman with antithrombin III deficiency.
        J Cardiol Cases. 2013; 7: e101-e103https://doi.org/10.1016/j.jccase.2012.11.005
        • Tu C.M.
        • Hsueg C.H.
        • Chu K.M.
        • Cheng S.M.
        • Tsao T.P.
        Simultaneous thromboses of double coronary arteries in a young male with antithrombin III deficiency.
        Am J Emerg Med. 2009; 27: e3-e6https://doi.org/10.1016/j.ajem.2008.12.006
        • Peovska I.
        • Maksimovic J.
        • Kalpak O.
        • Pejkov H.
        • Bosevski M.
        Recurrent myocardial infarction in a young football player with antithrombin III deficiency.
        Cardiol J. 2008; 15: 463-466
        • Pabinger I.
        • Thaler J.
        How I treat patients with hereditary antithrombin deficiency.
        Blood. 2019; 134: 2346-2353https://doi.org/10.1182/blood.2019002927